A detailed history of First Trust Advisors LP transactions in Geron Corp stock. As of the latest transaction made, First Trust Advisors LP holds 1,128,073 shares of GERN stock, worth $4.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,128,073
Previous 692,863 62.81%
Holding current value
$4.56 Million
Previous $2.94 Million 74.36%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.17 - $4.99 $1.81 Million - $2.17 Million
435,210 Added 62.81%
1,128,073 $5.12 Million
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $2.15 Million - $3.53 Million
692,863 New
692,863 $2.94 Million
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $1.38 Million - $2.14 Million
653,202 New
653,202 $1.38 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.53B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.